Drug eluting balloon system

A balloon and drug technology, applied in the direction of balloon-shaped catheters, catheters, coatings, etc., can solve the problems of limited drug release time, myocardial ischemia, balloon occlusion, etc., to promote drug absorption, increase binding area, increase binding effect

Inactive Publication Date: 2016-02-03
王显
View PDF8 Cites 15 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

At the same time, the existing drug balloon can infiltrate the drug into the vascular tissue through the filling of the balloon, but because the balloon blocks the blood flow, it can only be filled for about 40 seconds at most, otherwise it may cause myocardial ischemia, so the drug Limited release time and limited healing

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Drug eluting balloon system
  • Drug eluting balloon system

Examples

Experimental program
Comparison scheme
Effect test

Embodiment Construction

[0024] The present invention will be further described in detail below in conjunction with the accompanying drawings, so that those skilled in the art can implement it with reference to the description.

[0025] It should be understood that terms such as "having", "comprising" and "including" as used herein do not entail the presence or addition of one or more other elements or combinations thereof.

[0026] Such as figure 1 with figure 2 As shown, the present invention provides a drug-eluting balloon system comprising:

[0027] A balloon catheter 6, which has a guide wire lumen 5 arranged in the axial direction;

[0028] A drug-eluting balloon 1, which is arranged along a part of the length of the balloon catheter and inflated by means of a pressure medium provided by the balloon catheter, the outer surface of the balloon body 101 of the drug-eluting balloon 1 has drug coatings 102, 103;

[0029] Wherein, the drug coating 102, 103 includes an inner layer 102 and an outer ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

PropertyMeasurementUnit
concentrationaaaaaaaaaa
Login to view more

Abstract

The invention discloses a drug eluting balloon system which comprises a balloon catheter and a drug eluting balloon, wherein the balloon catheter is provided with a wire guide cavity arranged along the axial direction; the drug eluting balloon is arranged along the partial length of the balloon catheter and is expanded by virtue of a pressure medium provided by the balloon catheter; the external surface of the balloon body of the drug eluting balloon is provided with a drug coating; the drug coating comprises an inner layer and an outer layer, wherein the inner layer is a taxol and hirudin mixed drug coating, and the outer layer is a hirudin drug coating; a flow channel is also arranged in the wire guide cavity, and the flow channel is arranged at the partial length position of the balloon catheter; and the flow channel is provided with two openings which are respectively formed in two ends of the drug eluting balloon. When the drug eluting balloon system releases drugs, blood flow can not be blocked and drug release can be prolonged to any time, so that the action time of the drugs is increased and the curative effect is improved.

Description

technical field [0001] The invention relates to a medical device. More specifically, the present invention relates to a drug eluting balloon system. Background technique [0002] Percutaneous coronary intervention (PCI) has become the standard treatment for stenotic coronary artery disease. Drug-eluting balloon (DEB) can deliver and release drugs that inhibit restenosis to the treatment segment of blood vessels, and at the same time The lack of metal implants, which reduces the need for long-term dual antiplatelet therapy (DAPT), has received widespread attention since its birth. However, the incidence of short-term and mid-term restenosis after balloon dilatation and traditional stenting is as high as 5%-60%, which seriously limits the development of PCI. With the in-depth study on the mechanism of restenosis after coronary intervention and the successful development of drug-coated stent (DES), it is possible to prevent restenosis with DES. Even so, [0003] There is st...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Applications(China)
IPC IPC(8): A61M25/10A61L29/08A61L29/16
Inventor 王显
Owner 王显
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap